Sort
17,828 grants matching “crispr”
High-throughput development and characterization of compact tools for transcriptional and chromatin perturbations
$992,388Lacramioara Bintu · Stanford University · R01 · FY2021 · HG
NHGRI/DIR Genomics Core
$992,319Settara Chandrasekharappa · National Human Genome Research Institute · ZIC · FY2018 · HG
Regulatory Mechanisms of CD4+ T Cell Differentiation
$992,206Timothy E Reddy · Duke University · UM1 · FY2019 · HG
Roles of RNA-binding Proteins in Programming Gene Expression in Mammals
$991,499Stefan Muljo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Hearing regeneration in zebrafish
$991,078Shawn M Burgess · National Human Genome Research Institute · ZIA · FY2019 · HG
Zebrafish targeted mutagenesis and functional genomics
$991,078Shawn M Burgess · National Human Genome Research Institute · ZIA · FY2019 · HG
Scalable Development of Custom Genome Editing Technologies
$990,000Benjamin Peter Kleinstiver · Massachusetts General Hospital · DP2 · FY2025 · CA
Project 3
$989,330Alexander Marson · University Of California, San Francisco · U54 · FY2022 · AI
Discovery, Biology and Risk of Inherited Variants in Glioma
$989,011Melissa L Bondy · Stanford University · R01 · FY2021 · CA
CAREER: Understanding the evolution and genetic basis of meiotic recombination rate
$988,190Sen Xu · University Of Missouri-Columbia · · FY2023 · BIO
Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery
$987,822Justin Kawika Ichida · University Of Southern California · R01 · FY2023 · NS
Ocular Gene Therapy
$987,243Zhijian Wu · National Eye Institute · ZIA · FY2015 · EY
Predicting Cancer Cell Response to Endogenous and Exogenous Perturbations at the Single Cell Level
$987,000Andrea Califano · Columbia University Health Sciences · R35 · FY2022 · CA
From pathogenesis to new therapeutic targets in diffuse large B cell lymphoma
$987,000Riccardo Dalla-Favera · Columbia University Health Sciences · R35 · FY2023 · CA
From pathogenesis to new therapeutic targets in diffuse large B cell lymphoma
$987,000Riccardo Dalla-Favera · Columbia University Health Sciences · R35 · FY2025 · CA
Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells
$986,967Peter J Newman · Versiti Wisconsin, Inc. · R35 · FY2018 · HL
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$986,847Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells
$986,569Peter J Newman · Versiti Wisconsin, Inc. · R35 · FY2019 · HL
Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells
$986,569Peter J Newman · Versiti Wisconsin, Inc. · R35 · FY2023 · HL
Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells
$986,569Peter J Newman · Versiti Wisconsin, Inc. · R35 · FY2020 · HL
Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells
$986,569Peter J Newman · Versiti Wisconsin, Inc. · R35 · FY2021 · HL
Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells
$986,569Peter J Newman · Versiti Wisconsin, Inc. · R35 · FY2022 · HL
Identifying Metabolic Dependencies of Pancreatic Cancers
$986,490Alec Kimmelman · New York University School Of Medicine · R35 · FY2019 · CA
Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery
$986,054Justin Kawika Ichida · University Of Southern California · R01 · FY2024 · NS
RP3: Targeting ATG gene-dependent immunity for novel anti-infective therapeutics
$985,910Herbert W Virgin · Ut Southwestern Medical Center · U19 · FY2019 · AI